The second-generation BTK inhibitor acalabrutinib was approved for use with venetoclax. The U.S. Food and Drug Administration (FDA) approved acalabrutinib (Calquence) in combination with venetoclax (Venclexta) for adults with chronic lymphocytic leukemia (CLL) or...
Colorectal cancer cases are becoming more common in younger adults, but there are now more options for screening beyond colonoscopies.
Misinformation reaches most breast cancer survivors, and the FDA approves a treatment combination for platinum-resistant epithelial ovarian cancer.
The FDA has approved the portable device Optune Pax for non-invasive at-home treatment of locally advanced pancreatic cancer. The U.S. Food and Drug Administration (FDA) approved Optune Pax, a portable, noninvasive device for the...
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast cancer.
Pembrolizumab plus paclitaxel, with or without bevacizumab, was approved for PD-L1-positive ovarian, fallopian tube, and peritoneal cancers. The U.S. Food and Drug Administration (FDA) has approved pembrolizumab (Keytruda) as well as pembrolizumab and berahyaluronidase...
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
Study finds high consumption of ultraprocessed foods may be linked to increased risk of both all-cause and cancer-specific death. Ultraprocessed foods are often low in essential nutrients such as vitamins, minerals, and fiber, and...
Older adults with metastatic cancer are spending more time at medical appointments, and a biomarker test improves the odds of detecting pancreatic cancer.
The four-biomarker blood panel enhanced the detection of pancreatic cancer compared to standard testing. The pancreas aids with digestion and produces hormones, such as insulin and glucagon, that help regulate blood sugar levels. When...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More